Minden MD - Search Results

1

A primary hierarchically organized patient-derived model enables in depth interrogation of stemness driven by the coding and non-coding genome.

Boutzen H, Madani Tonekaboni SA, Chan-Seng-Yue M, Murison A, Takayama N, Mbong N, Wagenblast E, Orouji E, Arruda A, Mitchell A, Notta F, Minden MD, Lupien M, Kaufmann KB, Dick JE. Boutzen H, et al. Among authors: minden md. Leukemia. 2022 Nov;36(11):2690-2704. doi: 10.1038/s41375-022-01697-9. Epub 2022 Sep 21. Leukemia. 2022. PMID: 36131042 Free PMC article.

2

High-dose cytosine arabinoside remission induction for acute myelogenous leukemia: comparison of two regimens of remission maintenance.

Curtis JE, Messner HA, Minden MD, Lipton JH, Lockwood GA, Tritchler DL, McCulloch EA. Curtis JE, et al. Among authors: minden md. Leukemia. 1992 Nov;6(11):1192-8. Leukemia. 1992. PMID: 1434804 Clinical Trial.

3

Mast cell growth factor, a ligand for the receptor encoded by c-kit, affects the growth in culture of the blast cells of acute myeloblastic leukemia.

Wang C, Koistinen P, Yang GS, Williams DE, Lyman SD, Minden MD, McCulloch EA. Wang C, et al. Among authors: minden md. Leukemia. 1991 Jun;5(6):493-9. Leukemia. 1991. PMID: 1711640

4

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.

Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA, Dick JE. Lapidot T, et al. Nature. 1994 Feb 17;367(6464):645-8. doi: 10.1038/367645a0. Nature. 1994. PMID: 7509044

5

Influence of schedule on regulated sensitivity of AML blasts to cytosine arabinoside.

Yang GS, Minden MD, McCulloch EA. Yang GS, et al. Among authors: minden md. Leukemia. 1993 Jul;7(7):1012-9. Leukemia. 1993. PMID: 7686602

6

Regulation by retinoic acid and hydrocortisone of the anthracycline sensitivity of blast cells of acute myeloblastic leukemia.

Yang GS, Minden MD, McCulloch EA. Yang GS, et al. Among authors: minden md. Leukemia. 1994 Dec;8(12):2065-75. Leukemia. 1994. PMID: 7807996

7

Post-transcriptional regulation of bcl-2 in acute myeloblastic leukemia: significance for response to chemotherapy.

Hu ZB, Minden MD, McCulloch EA. Hu ZB, et al. Among authors: minden md. Leukemia. 1996 Mar;10(3):410-6. Leukemia. 1996. PMID: 8642855

8

A novel energy dependent mechanism reducing daunorubicin accumulation in acute myeloid leukemia.

Hedley DW, Xie SX, Minden MD, Choi CH, Chen H, Ling V. Hedley DW, et al. Among authors: minden md. Leukemia. 1997 Jan;11(1):48-53. doi: 10.1038/sj.leu.2400538. Leukemia. 1997. PMID: 9001418

9

High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase.

Wang JC, Lapidot T, Cashman JD, Doedens M, Addy L, Sutherland DR, Nayar R, Laraya P, Minden M, Keating A, Eaves AC, Eaves CJ, Dick JE. Wang JC, et al. Blood. 1998 Apr 1;91(7):2406-14. Blood. 1998. PMID: 9516140 Free article.

10

HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis.

Wong WW, Dimitroulakos J, Minden MD, Penn LZ. Wong WW, et al. Among authors: minden md. Leukemia. 2002 Apr;16(4):508-19. doi: 10.1038/sj.leu.2402476. Leukemia. 2002. PMID: 11960327 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

539 results

Search Page

Filters